<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gao H</submitter><funding>BLRD VA</funding><funding>NIDDK NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>U.S. Department of Veterans Affairs</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases</funding><pagination>565</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8799656</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(1)</volume><pubmed_abstract>Various microbial products leaked from gut lumen exacerbate tissue inflammation and metabolic disorders in obesity. Vsig4+ macrophages are key players preventing infiltration of bacteria and their products into host tissues. However, roles of islet Vsig4+ macrophages in the communication between microbiota and β cells in pathogenesis of obesity-associated islet abnormalities are unknown. Here, we find that bacterial DNAs are enriched in β cells of individuals with obesity. Intestinal microbial DNA-containing extracellular vesicles (mEVs) readily pass through obese gut barrier and deliver microbial DNAs into β cells, resulting in elevated inflammation and impaired insulin secretion by triggering cGAS/STING activation. Vsig4+ macrophages prevent mEV infiltration into β cells through a C3-dependent opsonization, whereas loss of Vsig4 leads to microbial DNA enrichment in β cells after mEV treatment. Removal of microbial DNAs blunts mEV effects. Loss of Vsig4+ macrophages leads to microbial DNA accumulation in β cells and subsequently obesity-associated islet abnormalities.</pubmed_abstract><journal>Nature communications</journal><pubmed_title>Accumulation of microbial DNAs promotes to islet inflammation and β cell abnormalities in obesity in mice.</pubmed_title><pmcid>PMC8799656</pmcid><funding_grant_id>R01 DK125560</funding_grant_id><funding_grant_id>P30 NS047101</funding_grant_id><funding_grant_id>R01CA179977</funding_grant_id><funding_grant_id>R01 CA179977</funding_grant_id><funding_grant_id>P30 DK063491</funding_grant_id><funding_grant_id>R00DK115998</funding_grant_id><funding_grant_id>R01DK125560</funding_grant_id><funding_grant_id>I01 BX003934</funding_grant_id><funding_grant_id>R00 DK115998</funding_grant_id><pubmed_authors>Tang K</pubmed_authors><pubmed_authors>Mahata S</pubmed_authors><pubmed_authors>Ly C</pubmed_authors><pubmed_authors>Luo Z</pubmed_authors><pubmed_authors>Sears DD</pubmed_authors><pubmed_authors>Ying W</pubmed_authors><pubmed_authors>Gao H</pubmed_authors><pubmed_authors>Ji Y</pubmed_authors><pubmed_authors>Jin Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>Accumulation of microbial DNAs promotes to islet inflammation and β cell abnormalities in obesity in mice.</name><description>Various microbial products leaked from gut lumen exacerbate tissue inflammation and metabolic disorders in obesity. Vsig4+ macrophages are key players preventing infiltration of bacteria and their products into host tissues. However, roles of islet Vsig4+ macrophages in the communication between microbiota and β cells in pathogenesis of obesity-associated islet abnormalities are unknown. Here, we find that bacterial DNAs are enriched in β cells of individuals with obesity. Intestinal microbial DNA-containing extracellular vesicles (mEVs) readily pass through obese gut barrier and deliver microbial DNAs into β cells, resulting in elevated inflammation and impaired insulin secretion by triggering cGAS/STING activation. Vsig4+ macrophages prevent mEV infiltration into β cells through a C3-dependent opsonization, whereas loss of Vsig4 leads to microbial DNA enrichment in β cells after mEV treatment. Removal of microbial DNAs blunts mEV effects. Loss of Vsig4+ macrophages leads to microbial DNA accumulation in β cells and subsequently obesity-associated islet abnormalities.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jan</publication><modification>2025-04-04T08:41:22.765Z</modification><creation>2025-04-04T08:41:22.765Z</creation></dates><accession>S-EPMC8799656</accession><cross_references><pubmed>35091566</pubmed><doi>10.1038/s41467-022-28239-2</doi></cross_references></HashMap>